TTOO vs. IRIX, XAIR, PTHL, CODX, BSGM, FEMY, NXGL, VVOS, PETV, and NRXS
Should you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include IRIDEX (IRIX), Beyond Air (XAIR), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), Co-Diagnostics (CODX), BioSig Technologies (BSGM), Femasys (FEMY), NEXGEL (NXGL), Vivos Therapeutics (VVOS), PetVivo (PETV), and NeurAxis (NRXS). These companies are all part of the "medical equipment" industry.
T2 Biosystems vs.
IRIDEX (NASDAQ:IRIX) and T2 Biosystems (NASDAQ:TTOO) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk, community ranking and valuation.
IRIDEX has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500.
20.1% of IRIDEX shares are held by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are held by institutional investors. 7.3% of IRIDEX shares are held by company insiders. Comparatively, 0.1% of T2 Biosystems shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
In the previous week, T2 Biosystems had 2 more articles in the media than IRIDEX. MarketBeat recorded 3 mentions for T2 Biosystems and 1 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.00 beat T2 Biosystems' score of -0.37 indicating that IRIDEX is being referred to more favorably in the media.
T2 Biosystems received 134 more outperform votes than IRIDEX when rated by MarketBeat users. However, 64.30% of users gave IRIDEX an outperform vote while only 63.64% of users gave T2 Biosystems an outperform vote.
IRIDEX has a net margin of -22.79% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat IRIDEX's return on equity.
IRIDEX currently has a consensus price target of $2.00, suggesting a potential upside of 21.21%. T2 Biosystems has a consensus price target of $5.00, suggesting a potential upside of 2,074.86%. Given T2 Biosystems' higher probable upside, analysts plainly believe T2 Biosystems is more favorable than IRIDEX.
IRIDEX has higher revenue and earnings than T2 Biosystems.
Summary
IRIDEX beats T2 Biosystems on 8 of the 14 factors compared between the two stocks.
Get T2 Biosystems News Delivered to You Automatically
Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
T2 Biosystems Competitors List
Related Companies and Tools
This page (NASDAQ:TTOO) was last updated on 1/21/2025 by MarketBeat.com Staff
Free TTOO Stock Alerts